Pharmaceuticals - Community Register

  

Community register of orphan medicinal products


GRANTED  

Product information

Nimorazole maleate

EU orphan designation number: EU/3/12/952   
Active ingredient: Nimorazole maleate
Indication: Treatment of squamous cell carcinoma of the head and neck in patients undergoing radiotherapy
Sponsor: Conventia Medical LLP
First Floor, St Peters House, Market Place, Tring, Herts HP23 5AE, United Kingdom

   Public summary of scientific opinion    

 

European Commission proceduresGoto top of the page

Close date procedure Procedure type EMEA number Decision summary publ decision docs annex
13/02/2012 Centralised Orphan - Designation EMA/OD/099/11 (2012)878 of 09/02/2012